Ultrasonic Neuromodulation of Cingulate Cortex for Fibromyalgia
NCT07226648
This study is recruiting at 8 US sites in 7 states, according to its ClinicalTrials.gov record last updated .
Summary
The goal of this clinical trial is to evaluate a new noninvasive brain stimulation intervention for fibromyalgia and to determine its effectiveness in reducing pain. Participants will receive four treatments over the course of one month and will complete surveys at multiple time points throughout the 16-week study.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Fibromyalgia
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 22 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- SPIRE Therapeutics Inc.
- Last updated on ClinicalTrials.gov
- August 20, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Michigan · 1
- University of Michigan · Ann Arbor, MI
Minnesota · 1
- University of Minnesota Medical Center Fairview · Minneapolis, MN
Missouri · 1
- Washington University in St. Louis · St Louis, MO
New York · 2
- Northwell Health - The Feinstein Institutes of Clinical Research · Manhasset, NY
- Icahn School of Medicine at Mount Sinai · New York, NY
Pennsylvania · 1
- University of Pennsylvania · Philadelphia, PA
Utah · 1
- University of Utah · Salt Lake City, UT
West Virginia · 1
- WVU Rockefeller Neuroscience Institute · Morgantown, WV
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.